|
Category: pharmaceuticals / chemical synthisis
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Melting Point: | 150.00 °C. @ 760.00 mm Hg
|
| Flash Point: | 32.00 °F. TCC ( 0.00 °C. ) (est)
|
| logP (o/w): | -3.904 (est) |
| Soluble in: |
| | water, 1e+006 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
parenteral-frog LDLo 200 mg/kg CARDIAC: OTHER CHANGES
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
BEHAVIORAL: STIFFNESS Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 166, Pg. 437, 1932.
unreported-frog LDLo 500 mg/kg PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 164, Pg. 346, 1932.
intravenous-guinea pig LD50 7700 ug/kg Archives Internationales de Pharmacodynamie et de Therapie. Vol. 170, Pg. 461, 1967.
intraperitoneal-mouse LD50 15300 ug/kg LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Farmakologiya i Toksikologiya Vol. 20(4), Pg. 32, 1957.
intravenous-mouse LD50 10 mg/kg PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE Journal of Pharmacology and Experimental Therapeutics. Vol. 119, Pg. 541, 1957.
oral-mouse LD50 3000 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936.
intravenous-rat LD50 22 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936.
oral-rat LD50 2500 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936.
|
| Dermal Toxicity: |
subcutaneous-mouse LD50 170 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936.
subcutaneous-rat LD50 250 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | pharmaceuticals / chemical synthisis |
| Recommendation for acetyl choline chloride usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for acetyl choline chloride flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | acecholin | | | acecoline | | 2- | acetoxy-N,N,N-trimethylethanaminium chloride | | 2- | acetoxy-N,N,N-trimethylethanium chloride | | 2- | acetoxyethyltrimethylammonium chloride | | | acetyl choline chloride USP | | | acetylcholine chloride | | | acetylcholine hydrochloride | | | acetylcholinechloride | | | acetylcholinium chloride | | 2- | acetyloxy-N,N,N-trimethylethanaminium chloride | | 2- | acetyloxy-N,N,N-trimethylethanium chloride | | 2-( | acetyloxy)-N,N,N-trimethylethanaminium chloride | | [2-( | acetyloxy)ethyl]trimethylazanium chloride | | 2- | acetyloxyethyl-trimethyl-azanium | | 2- | acetyloxyethyl(trimethyl)azanium;chloride | | | ethanaminium, 2-(acetyloxy)-N,N,N-trimethyl-, chloride (1:1) | | (2- | hydroxyethyl)trimethylammonium chloride acetate | | 2-( | trimethylamino)ethyl acetate, chloride |
Articles:
|